Acute Renal Failure With Cocaine and SGLT-2 Inhibitor

被引：2
|
作者：
Shrivastava, Snehal [1 ]
Srivastava, Nishit [2 ]
Alfanso-Jaume, Maria [1 ]
机构：
[1] Univ Toledo, Med Ctr, Div Nephrol, 2801 W Bancroft St, Toledo, OH 43606 USA
[2] Mercy St Vincent Med Ctr, Dept Internal Med, Toledo, OH USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2019年 / 26卷 / 06期
关键词：
ACUTE KIDNEY INJURY; EMPAGLIFLOZIN; DISEASE;
D O I：
10.1097/MJT.0000000000000929
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E762 / E763
页数：3
相关论文
共 50 条
  • [41] Correlates and Consequences of an Acute Decline in Estimated Glomerular Filtration Rate in Response to the SGLT-2 Inhibitor Dapagliflozin
    Heerspink, Hiddo J. L.
    Jongs, Niels
    Chertow, Glenn M.
    Langkilde, Anna Maria
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur V.
    Toto, Robert D.
    Greene, Tom
    Wheeler, David C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 726 - 726
  • [42] A Practical Stereoselective Synthesis and Novel Cocrystallizations of an Amphiphatic SGLT-2 Inhibitor
    Deshpande, Prashant P.
    Singh, Janak
    Pullockaran, Annie
    Kissick, Thomas
    Ellsworth, Bruce A.
    Gougoutas, Jack Z.
    Dimarco, John
    Fakes, Michael
    Reyes, Mayra
    Lai, Chiajen
    Lobinger, Hidegard
    Denzel, Theo
    Ermann, Peter
    Crispino, Gerard
    Randazzo, Michael
    Gao, Zenrong
    Randazzo, Renee
    Lindrud, Mark
    Rosso, Victor
    Buono, Frederic
    Doubleday, Wendel W.
    Leun, Simon
    Richberg, Pricilla
    Hughes, David
    Washburn, William N.
    Meng, Wei
    Volk, Kevin J.
    Mueller, Richard H.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (04) : 577 - 585
  • [43] FAERS reports of acute renal failure with SGLT2 inhibitors
    Reactions Weekly, 2021, 1843 (1) : 7 - 7
  • [44] Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?
    Georgianos, Panagiotis, I
    Eleftheriadis, Theodoros
    Liakopoulos, Vassilios
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (02)
  • [45] SGLT-2 inhibitor-related genital tract infections and UTIs
    Reactions Weekly, 2023, 1976 (1) : 10 - 10
  • [46] The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients
    Sheu, Jia-Yuh
    Chang, Li-Yang
    Chen, Jui-Yi
    Pan, Heng-Chih
    Tseng, Chi-Shin
    Chueh, Jeff S.
    Wu, Vin-Cent
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [47] Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (02): : S13 - S16
  • [48] Fournier's Gangrene: A Coexistence or Consanguinity of SGLT-2 Inhibitor Therapy
    Chowdhury, Tutul
    Gousy, Nicole
    Bellamkonda, Amulya
    Dutta, Jui
    Zaman, Chowdhury F.
    Zakia, Ummul B.
    Tasha, Tasniem
    Dutta, Priyata
    Roy, Padmaja Deb
    Gomez, Adriana M.
    Mainali, Arjun
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [49] Use of SGLT-2 inhibitor in COVID-19: A cautionary tale
    Yousaf, Zohaib
    Munir, Waqar
    Hammamy, Riyadh Ali Mohammed
    MEDCOMM, 2021, 2 (01): : 114 - 116
  • [50] Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers
    Dekkers, Claire C. J.
    Petrykiv, Sergei
    Laverman, Gozewijn D.
    Cherney, David Z.
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    DIABETES OBESITY & METABOLISM, 2018, 20 (08): : 1988 - 1993
12345